Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...